drugset / Trial / NCT03572491
Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine
Phase 3
Completed
2000 enrolled
Research Institute for Biological Safety Problems
Asfendiyarov Kazakh National Medical University · collabResearch Institute of Influenza, Russia · collab
NaSingle-groupOpen-labelPrevention
Summary
The study is Multicenter, phase 3, Open-Label trial that explored the preventive effectiveness, safety and immunogenicity of single dose a allantoic split inactivated seasonal influenza vaccine in healthy adults.
Timeline
- Start
- 2017-09-18
- Primary completion
- 2018-05-21
- Completion
- 2018-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | — | Intramuscular |